261 related articles for article (PubMed ID: 12570381)
1. Preparation of 7-substituted ginkgolide derivatives: potent platelet activating factor (PAF) receptor antagonists.
Vogensen SB; Strømgaard K; Shindou H; Jaracz S; Suehiro M; Ishii S; Shimizu T; Nakanishi K
J Med Chem; 2003 Feb; 46(4):601-8. PubMed ID: 12570381
[TBL] [Abstract][Full Text] [Related]
2. Ginkgolide derivatives for photolabeling studies: preparation and pharmacological evaluation.
Strømgaard K; Saito DR; Shindou H; Ishii S; Shimizu T; Nakanishi K
J Med Chem; 2002 Aug; 45(18):4038-46. PubMed ID: 12190325
[TBL] [Abstract][Full Text] [Related]
3. Ginkgolides and glycine receptors: a structure-activity relationship study.
Jaracz S; Nakanishi K; Jensen AA; Strømgaard K
Chemistry; 2004 Mar; 10(6):1507-18. PubMed ID: 15034895
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three paf-acether receptor antagonist ginkgolides.
Korth R; Nunez D; Bidault J; Benveniste J
Eur J Pharmacol; 1988 Jul; 152(1-2):101-10. PubMed ID: 2850196
[TBL] [Abstract][Full Text] [Related]
5. Ginkgolides: selective acetylations, translactonization, and biological evaluation.
Jaracz S; Strømgaard K; Nakanishi K
J Org Chem; 2002 Jun; 67(13):4623-6. PubMed ID: 12076171
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hippocampal LTP by ginkgolide B is mediated by its blocking action on PAF rather than glycine receptors.
Kondratskaya EL; Pankratov YV; Lalo UV; Chatterjee SS; Krishtal OA
Neurochem Int; 2004 Feb; 44(3):171-7. PubMed ID: 14568560
[TBL] [Abstract][Full Text] [Related]
7. Sensitization of human neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761.
Lenoir M; Pedruzzi E; Rais S; Drieu K; Perianin A
Biochem Pharmacol; 2002 Apr; 63(7):1241-9. PubMed ID: 11960600
[TBL] [Abstract][Full Text] [Related]
8. Species difference in the specific receptors of platelet activating factor.
Hwang SB; Lam MH
Biochem Pharmacol; 1986 Dec; 35(24):4511-8. PubMed ID: 3024653
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of the platelet-activating factor receptor antagonists, CV-3988 and Ginkgolide B, on alkali burn-induced corneal neovascularization.
Lee CM; Jung WK; Na G; Lee DS; Park SG; Seo SK; Yang JW; Yea SS; Lee YM; Park WS; Choi IW
Cutan Ocul Toxicol; 2015 Mar; 34(1):53-60. PubMed ID: 24754407
[TBL] [Abstract][Full Text] [Related]
10. Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus.
Lee CM; Jiang LM; Shang HS; Hon PM; He Y; Wong HN
Br J Pharmacol; 1991 Jul; 103(3):1719-24. PubMed ID: 1657264
[TBL] [Abstract][Full Text] [Related]
11. [Platelet-activating factor (PAF) antagonists].
Terasawa M
Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
[No Abstract] [Full Text] [Related]
12. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes.
Földes-Filep E; Braquet P; Filep J
Biochem Biophys Res Commun; 1987 Nov; 148(3):1412-7. PubMed ID: 2825685
[TBL] [Abstract][Full Text] [Related]
13. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets.
Robaut C; Durand G; James C; Lave D; Sedivy P; Floch A; Mondot S; Pacot D; Cavero I; Le Fur G
Biochem Pharmacol; 1987 Oct; 36(19):3221-9. PubMed ID: 2822048
[TBL] [Abstract][Full Text] [Related]
14. Alkyl and alkoxycarbonyl derivatives of ginkgolide B: synthesis and biological evaluation of PAF inhibitory activity.
Hu L; Chen Z; Xie Y; Jiang Y; Zhen H
Bioorg Med Chem; 2000 Jun; 8(6):1515-21. PubMed ID: 10896127
[TBL] [Abstract][Full Text] [Related]
15. Ginkgolide B reduces inflammatory protein expression in oxidized low-density lipoprotein-stimulated human vascular endothelial cells.
Zhang S; Chen B; Wu W; Bao L; Qi R
J Cardiovasc Pharmacol; 2011 Jun; 57(6):721-7. PubMed ID: 21436722
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
[TBL] [Abstract][Full Text] [Related]
17. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis.
Biancone L; Cantaluppi V; Boccellino M; Bussolati B; Del Sorbo L; Conaldi PG; Albini A; Toniolo A; Camussi G
Am J Pathol; 1999 Nov; 155(5):1731-9. PubMed ID: 10550329
[TBL] [Abstract][Full Text] [Related]
18. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3.
Hostettler ME; Knapp PE; Carlson SL
Glia; 2002 May; 38(3):228-39. PubMed ID: 11968060
[TBL] [Abstract][Full Text] [Related]
20. Recent progress in ginkgolide research.
Braquet P; Esanu A; Buisine E; Hosford D; Broquet C; Koltai M
Med Res Rev; 1991 May; 11(3):295-355. PubMed ID: 1647474
[No Abstract] [Full Text] [Related]
[Next] [New Search]